JP2021525512A5 - - Google Patents
Info
- Publication number
- JP2021525512A5 JP2021525512A5 JP2020566267A JP2020566267A JP2021525512A5 JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5 JP 2020566267 A JP2020566267 A JP 2020566267A JP 2020566267 A JP2020566267 A JP 2020566267A JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- cdr2
- cdr3
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678080P | 2018-05-30 | 2018-05-30 | |
| US62/678,080 | 2018-05-30 | ||
| PCT/US2019/034259 WO2019231957A1 (en) | 2018-05-30 | 2019-05-29 | Anti-abeta antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525512A JP2021525512A (ja) | 2021-09-27 |
| JP2021525512A5 true JP2021525512A5 (enExample) | 2022-05-20 |
| JP7210612B2 JP7210612B2 (ja) | 2023-01-23 |
Family
ID=68694402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566267A Active JP7210612B2 (ja) | 2018-05-30 | 2019-05-29 | 抗ａベータ抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11084873B2 (enExample) |
| EP (1) | EP3801618A4 (enExample) |
| JP (1) | JP7210612B2 (enExample) |
| KR (1) | KR102523019B1 (enExample) |
| CN (1) | CN112601550B (enExample) |
| CA (1) | CA3100896C (enExample) |
| TW (1) | TWI721440B (enExample) |
| WO (1) | WO2019231957A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101325972B (zh) * | 2005-12-12 | 2020-06-16 | Ac免疫有限公司 | 具有治疗性质的Aβ1-42特异性单克隆抗体 |
| EP1959996A2 (en) * | 2005-12-12 | 2008-08-27 | AC Immune S.A. | Monoclonal antibody |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| EP2527369A3 (en) * | 2007-09-13 | 2012-12-19 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| CA2705509A1 (en) * | 2007-11-14 | 2009-05-22 | Forerunner Pharma Research Co., Ltd. | Diagnosis and treatment of cancer using anti-gpr49 antibody |
| EP2207568B1 (en) * | 2007-11-16 | 2017-05-31 | The Rockefeller University | Antibodies specific for the protofibril form of beta-amyloid protein |
| WO2011016238A1 (en) * | 2009-08-06 | 2011-02-10 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| US20150315267A1 (en) | 2012-12-07 | 2015-11-05 | Thierry Bussiere | A method of reducing brain amyloid plaques using anti-ab antibodies |
| WO2014151747A1 (en) * | 2013-03-15 | 2014-09-25 | Ramot At Tel Aviv University Ltd. | Methods and compositions with immune therapy for treatment of dementia |
| RU2699717C2 (ru) * | 2014-04-18 | 2019-09-09 | Дзе Ресёч Фаундэйшен Фор Дзе Штат Юниверсити Ов Нью-Йорк | Гуманизированные антитела к антигену Томсена-Фриденрайха |
| KR102776187B1 (ko) * | 2015-11-09 | 2025-03-07 | 더 유니버시티 오브 브리티쉬 콜롬비아 | 아밀로이드 베타에서의 n-말단 에피토프 및 이에 형태적으로-선택적인 항체 |
| EP4063858A1 (en) * | 2016-03-14 | 2022-09-28 | Biogen International Neuroscience GmbH | Antibody-dependent cell-mediated phagocytosis assay for reliably measuring uptake of aggregated proteins |
-
2019
- 2019-05-29 WO PCT/US2019/034259 patent/WO2019231957A1/en not_active Ceased
- 2019-05-29 CN CN201980036565.6A patent/CN112601550B/zh active Active
- 2019-05-29 JP JP2020566267A patent/JP7210612B2/ja active Active
- 2019-05-29 CA CA3100896A patent/CA3100896C/en active Active
- 2019-05-29 EP EP19811193.2A patent/EP3801618A4/en active Pending
- 2019-05-29 KR KR1020207034600A patent/KR102523019B1/ko active Active
- 2019-05-30 US US16/426,585 patent/US11084873B2/en active Active
- 2019-05-30 TW TW108118733A patent/TWI721440B/zh active